ClinicalTrials.Veeva

Menu

Multimodality Evaluation of LAA Leaks Arising After Incomplete LAAC: Insights From the LAA-Leak Registry

Kansas City Heart Rhythm Research Foundation logo

Kansas City Heart Rhythm Research Foundation

Status

Completed

Conditions

Left Atrail Appendage Closure: Peri-device Leaks

Treatments

Other: leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA

Study type

Observational

Funder types

Other

Identifiers

NCT05131308
KCHRF-LAA Leak Registry-0007

Details and patient eligibility

About

Closure of peri-device leaks (PDL) after incomplete LAAC have shown early feasibility, however no comparison study of all the leak closure modalities exists. Therefore, this is an attempt to report the first 3-way observational comparison study to date, with results in 160 total patients in 3 arms including detachable embolization coils, vascular plugs/septal occluders and Radiofrequency ablation.

Full description

Left Atrial Appendage (LAA) Closure (LAAC) is a potent technique of LAA isolation and exclusion for stroke prevention in patients with atrial fibrillation, with evidence from the PROTECT-AF and PREVAIL-AF trials, including their 5-year follow-up assessments, solidifying LAAC as a viable option in these patients with comparable stroke reduction in comparison to oral anticoagulation (OAC) as well as a reduction in bleeding risk, hemorrhagic CVA, and mortality. However, the surge in the multiple methods of LAA exclusion has also brought to attention postprocedural complications specific to LAAC, namely, peri-device leaks (PDL). The stroke implication and classification of PDL itself still lacks consensus, with an increased thromboembolic (TE) potential due to PDL seen in patients with LARIAT and surgical ligation procedures, yet no statistically significant relationship seen in percutaneous and endocardial LAA closure approaches. PDL > 5mm has been widely accepted as clinically significant, although there remains limited data with no current established guidelines. Placement of a septal occluder device such as Amplatzer Vascular Plug, Detachable embolization coils, Gore Cardioform Septal Occluder (CSO; W.L. Gore and Associates, Newark DE), and radiofrequency ablation (RFA) have all emerged as options to resolve residual PDL and post-surgical/ligation leaks. However, there exists no head-to-head comparison between these modalities. Given their emergence, this is a proposed a multi-center observational study to further assess and evaluate these three treatment modalities for their efficacy for leak closure, assessment of pre-, peri- and post-procedural characteristics after leak closure, TE events, and bleeding risk, and complication rates.

Enrollment

160 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients at risk for stroke or thromboembolism that demonstrated any degree of the significant leak on follow up TEE imaging at least 4-6 weeks following either epicardial, endocardial, or surgical LAAC
  2. Patients undergoing any form of eccentric or centric/central leak closure with available modalities (detachable embolization coils, vascular plus/septal/ASD occluders, or RF Ablation). Criteria for this was made based on the judgement of the operator, with no specific cutoffs for leak size, follow-up time from LAAC to leak closure, etc)
  3. Age greater than 18 years

Exclusion criteria

  1. Patients not undergoing leak closure after incomplete LAAC
  2. Patients unable to complete 45 day follow-up imaging for reevaluation of LAA leak
  3. Patients unable to consent

Trial design

160 participants in 3 patient groups

Detachable embolization coils group
Description:
Patients who have an intervention for leak closure with detachable embolization coils
Treatment:
Other: leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA
Vascular plugs/septal occluders group
Description:
Patients who have an intervention for leak closure with vascular plugs/CSO
Treatment:
Other: leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA
RF Ablation group
Description:
Patients who have an intervention for leak closure with Radio Frequency Ablation (RFA)
Treatment:
Other: leak closure with either detachable embolization coils, vascular plugs/CSO, or RFA

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems